22nd Oncology Updates: Advanced and Controversies

---

LIVESurgerySurgical OncologyOncologyMulti-Disciplinary Oncology

Friday, January 16, 2026, 7:00 AM - Monday, January 19, 2026, 12:00 PM, Steamboat Grand Hotel, Steamboat Springs, CO


AMA PRA Category 1 Credits™ (19.25 hours), ABS CC (19.25 hours), Non-Physician Attendance (19.25 hours)

The 22nd Oncology Updates: Advances in Controversies Conference offers an interactive, multidisciplinary forum designed to address the evolving complexities of solid tumor management. As the treatment landscape rapidly advances, clinicians must remain informed about emerging therapies and their application across various stages of disease. Increasingly, interventions once reserved for advanced cancers are being utilized in earlier, potentially curative settings, requiring a deeper understanding of both foundational principles and cutting-edge developments. This conference convenes leading experts from surgical oncology, medical oncology, radiation oncology, pathology, radiology, cancer prevention, and symptom management to explore current challenges, novel therapies, and clinical controversies. Through case-based discussions and evidence-driven presentations, participants will gain the knowledge and skills needed to integrate preclinical and clinical data into practice. The ultimate goal is to equip healthcare professionals with the tools to deliver the highest standard of care to patients with solid tumors.

1. Applying an evidence-based sequence of surgical, radiation, and systemic therapies, including immunotherapies and molecular-targeted treatments, for solid tumors such as head and neck, gastrointestinal, melanoma, lung, breast, gynecologic, and genitourinary cancers.
2. Evaluating and selecting optimal treatment strategies for patients across various disease stages, clinical presentations, and comorbidities, using case-based scenarios to guide decision-making.
3. Integrating preventive strategies, screening protocols, and symptom management into comprehensive oncology care to enhance patient outcomes and quality of life.

On-site registration for the 22nd Annual Oncology Update: Advances and Controversies, will open at 6:30 AM on Friday, January 16, 2026, and the conference will begin at 7:00 AM. The conference will adjourn at 10:00 am on Monday, January 19, 2025.  Advanced registration is encouraged as space and materials are limited.  Please see registration form for applicable fees.

Advanced registration is encouraged. The deadline for advanced registration is January 5, 2026.

Agenda coming soon!

Registration Fees:

REGISTRATION CATEGORY	BEFORE JAN. 5	After JAN. 5	ON-SITE
Non-MD Anderson Physicians	$700	$750	$800
MD Anderson Faculty/Physicians	$650	$700	$800
Other Healthcare Professionals	$400	$450	$500
Oncology Update Guest Ticket (Meals Only)	$300	$350	$350
Scientists	$650	$650	$700

Telephone registrations are not accepted.

We accept the following forms of payment:
Credit Cards (MasterCard, VISA, and American Express)
Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on your profile during the process. 
 
Refund/Cancellation Policy
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before January 5, 2026.  No refunds will be granted after this date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Special Assistance or Additional Information
Contact Continuing Professional Education/Activity Management at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status.  Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. 

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Exhibitor Registration Requirements

• Registration & Agreement: To participate as an exhibitor, both registration and a signed exhibit agreement are required.

• Confirmation Process: Your exhibit is only confirmed after completing registration and submitting a fully executed agreement.

• Payment Timeline: The signed agreement and payment must be submitted prior to the event.

• Additional Badges: Extra exhibitor badges can only be purchased by companies with confirmed exhibitor status.

• Support Clarification: Grant and in-kind support are independent and separate from exhibitor fees.

Click Here to View the Letter of Request

W9 Form Exhibit at this Event